Cutting edge: IL-2 signals determine the degree of TCR signaling necessary to support regulatory T cell proliferation in vivo

Journal of Immunology

Volumn 189, Issue 1, 2012, Pages 28-32

  Zou, Tao ^a   Satake, Atsushi ^a   Corbo Rodgers, Evann ^b   Schmidt, Amanda M ^a   Farrar, Michael A ^c   Maltzman, Jonathan S ^b   Kambayashi, Taku ^a,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STAT5 PROTEIN; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIVISION; CELL SPECIFICITY; CONTROLLED STUDY; IMMUNOLOGICAL TOLERANCE; IN VIVO STUDY; INTRACELLULAR SIGNALING; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; STEADY STATE; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION INITIATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELL PROLIFERATION; HOMEOSTASIS; INTERLEUKIN-2; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, INTERLEUKIN-2; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 84862856290     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200507     Document Type: Article

References (20)

1. Wing, K., and S. Sakaguchi. 2010. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 11: 7-13.
2. Fisson, S., G. Darrasse-Jèze, E. Litvinova, F. Septier, D. Klatzmann, R. Liblau, and B. L. Salomon. 2003. Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state. J. Exp. Med. 198: 737-746. (Pubitemid 37087773)
3. Setoguchi, R., S. Hori, T. Takahashi, and S. Sakaguchi. 2005. Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 201: 723-735. (Pubitemid 40395118)
4. Cheng, G., A. Yu, and T. R. Malek. 2011. T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. Immunol. Rev. 241: 63-76.
5. Webster, K. E., S. Walters, R. E. Kohler, T. Mrkvan, O. Boyman, C. D. Surh, S. T. Grey, and J. Sprent. 2009. In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J. Exp. Med. 206: 751-760.
6. Bhandoola, A., X. Tai, M. Eckhaus, H. Auchincloss, K. Mason, S. A. Rubin, K. M. Carbone, Z. Grossman, A. S. Rosenberg, and A. Singer. 2002. Peripheral expression of self-MHC-II influences the reactivity and self-tolerance of mature CD4(+) T cells: evidence from a lymphopenic T cell model. Immunity 17: 425-436. (Pubitemid 35223532)
7. Gavin, M. A., S. R. Clarke, E. Negrou, A. Gallegos, and A. Rudensky. 2002. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat. Immunol. 3: 33-41. (Pubitemid 34065615)
8. Kim, J. K., M. Klinger, J. Benjamin, Y. Xiao, D. J. Erle, D. R. Littman, and N. Killeen. 2009. Impact of the TCR signal on regulatory T cell homeostasis, function, and trafficking. PLoS One 4: e6580.
9. Shen, S., M. I. Chuck, M. Zhu, D. M. Fuller, C.-W. O. Yang, and W. Zhang. 2010. The importance of LAT in the activation, homeostasis, and regulatory function of T cells. J. Biol. Chem. 285: 35393-35405.
10. Swee, L., N. Bosco, B. Malissen, R. Ceredig, and A. Rolink. 2009. Expansion of peripheral nTreg by FLT3L treatment. Blood 113: 6277-6287.
11. Zou, T., A. J. Caton, G. A. Koretzky, and T. Kambayashi. 2010. Dendritic cells induce regulatory T cell proliferation through antigen-dependent and -independent interactions. J. Immunol. 185: 2790-2799.
12. Wu, G. F., E. Corbo, M. Schmidt, J. E. Smith-Garvin, M. J. Riese, M. S. Jordan, T. M. Laufer, E. J. Brown, and J. S. Maltzman. 2011. Conditional deletion of SLP-76 in mature T cells abrogates peripheral immune responses. Eur. J. Immunol. 41: 2064-2073.
13. Burchill, M. A., J. Yang, C. Vogtenhuber, B. R. Blazar, and M. A. Farrar. 2007. IL- 2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 178: 280-290. (Pubitemid 46033611)
14. Martin, W. D., G. G. Hicks, S. K. Mendiratta, H. I. Leva, H. E. Ruley, and L. Van Kaer. 1996. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 84: 543-550. (Pubitemid 26071735)
15. Maltzman, J. S., L. Kovoor, J. L. Clements, and G. A. Koretzky. 2005. Conditional deletion reveals a cell-autonomous requirement of SLP-76 for thymocyte selection. J. Exp. Med. 202: 893-900. (Pubitemid 41396889)
16. Föhse, L., J. Suffner, K. Suhre, B. Wahl, C. Lindner, C.-W. Lee, S. Schmitz, J. D. Haas, S. Lamprecht, C. Koenecke, et al. 2011. High TCR diversity ensures optimal function and homeostasis of Foxp3+ regulatory T cells. Eur. J. Immunol. 41: 3101-3113.
17. Zhang, H., K. S. Chua, M. Guimond, V. Kapoor, M. V. Brown, T. A. Fleisher, L. M. Long, D. Bernstein, B. J. Hill, D. C. Douek, et al. 2005. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nat. Med. 11: 1238-1243. (Pubitemid 43093672)
18. Tang, Q., J. Y. Adams, C. Penaranda, K. Melli, E. Piaggio, E. Sgouroudis, C. A. Piccirillo, B. L. Salomon, and J. A. Bluestone. 2008. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity 28: 687-697.
19. Shin, H. J., J. Baker, D. B. Leveson-Gower, A. T. Smith, E. I. Sega, and R. S. Negrin. 2011. Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells. Blood 118: 2342-2350.
20. Koreth, J., K. Matsuoka, H. T. Kim, S. M. McDonough, B. Bindra, E. P. Alyea, III, P. Armand, C. Cutler, V. T. Ho, N. S. Treister, et al. 2011. Interleukin-2 and regulatory T cells in graft-versus-host disease. N. Engl. J. Med. 365: 2055-2066.